NCT04594473 A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors Status COMPLETED Phase NA
NCT04591431 The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04590560 What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? Status RECRUITING Phase NA
NCT04587258 Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island Status UNKNOWN Phase N/A
NCT04586335 Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. Status TERMINATED Phase PHASE1
NCT04585750 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Status RECRUITING Phase PHASE1/PHASE2
NCT04584775 Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care Status WITHDRAWN Phase NA
NCT04584255 Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04582968 Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases Status UNKNOWN Phase PHASE1/PHASE2
NCT04580784 Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer Status UNKNOWN Phase PHASE2
NCT04579107 KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer Status RECRUITING Phase NA
NCT04579029 PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema Status UNKNOWN Phase NA
NCT04574609 Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04574323 Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy Status COMPLETED Phase NA
NCT04574063 PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk Status UNKNOWN Phase NA
NCT04571437 Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study) Status UNKNOWN Phase PHASE2